PressReader
Catalog
For You
Category - GlaxoSmithKline
GSK says antibody drug extended lives of those with blood cancer
GSK BENEFITS FROM RSV VACCINE
GSK to pay 23andMe $20m to access consumer DNA data
Drugmaker to pay 23andme $20 million to access DNA for medical research
GSK settles Zantac suit before trial
New RSV vaccines from Pfizer, GSK set for $2B in sales
New RSV vaccines from GSK, Pfizer on track for $2 billion in sales
RSV vaccines from Pfizer and GSK are on track for $2 billion in sales
Pfizer and GSK shots to prevent RSV get health panel approval
GSK’S NEW RSV VACCINE LASTS TWO SEASONS
GSK breathes hope into respiratory biz in country
GSK to buy biotech Bellus Health for $2B
GSK to buy biotech Bellus Health for $2B
GSK to buy Canadian biotech that developed new cough medicine
FDA advisers support GSK’s RSV vaccine
GSK’s RSV vaccine gets approval of advisory panel
FDA advisers support GSK’s RSV vaccine
GSK says shot for HIV easier to take than pills
GSK to expand in Cambridge
Cambridge firm, GSK in deal on RNA editing
GSK shares surge as US judge dismisses Zantac cancer claims
Cogent Biosciences hires clinical development leader for GSK